http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101247350-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2010-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101247350-B1 |
| titleOfInvention | Novel anti-inflammatory peptide derivatives and uses thereof |
| abstract | The present invention provides an anti-inflammatory salt of the antibiotic peptide 9Pbw 3, or 9Pbw3D (SEQ ID NOs: 3 and 4), which is designed based on the 9 residue sequences of the α-helix region of protaetiamycin isolated from Protaetia brevitarsis larvae. It relates to the use and mechanism of action for the activity. Peptides of the present invention exhibits anti-inflammatory activity by inhibiting the production of the inflammatory inducer nitrite oxide and cytokines, and can be usefully used as a safe inflammatory therapeutic for humans because there is no cytotoxicity in the concentration range showing anti-inflammatory activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102291069-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102290200-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102290204-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102290215-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102290226-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102266613-B1 |
| priorityDate | 2010-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.